T-group (topology)
103.5.1 post-HMGL domain-like
Ligands and drugs
741
Member domains
130
with ligand contacts (≤ 4 Å)
17.5% of members
130
with DrugDomain annotations
17.5% of members
93
with a DrugBank compound
12.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 103.5.1 belongs to X-group 103 RuvA-C, which binds 8.6 ligand superclasses per 20 proteins, broader than 69% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07497 | BTI | 5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal | 37 |
| DB00119 | PYR | Pyruvic acid | 27 |
| DB00121 | BTN | Biotin | 6 |
| DB02951 | 3PY | 3-Hydroxypyruvic Acid | 4 |
| DB03940 | OXM | Oxamic Acid | 4 |
| DB17135 | BPV | Bromopyruvate | 4 |
| DB02637 | OAA | Oxaloacetate Ion | 3 |
| DB00123 | LYS | Lysine | 2 |
| DB01992 | COA | Coenzyme A | 2 |
| DB03843 | FOR | Formaldehyde | 1 |
| DB08845 | AKG | Oxogluric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PYR | PYRUVIC ACID | 37 |
| CL | CHLORIDE ION | 32 |
| BTI | 5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL | 25 |
| BYT | Biocytin | 8 |
| BTN | BIOTIN | 7 |
| 3PY | 3-HYDROXYPYRUVIC ACID | 4 |
| BPV | Bromopyruvate | 4 |
| OXM | OXAMIC ACID | 4 |
| COA | COENZYME A | 2 |
| LYS | LYSINE | 2 |
| OAA | OXALOACETATE ION | 2 |
| NAmetal | SODIUM ION | 1 |